1. Home
  2. HELE vs LQDA Comparison

HELE vs LQDA Comparison

Compare HELE & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HELE
  • LQDA
  • Stock Information
  • Founded
  • HELE 1968
  • LQDA 2004
  • Country
  • HELE United States
  • LQDA United States
  • Employees
  • HELE N/A
  • LQDA N/A
  • Industry
  • HELE Home Furnishings
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HELE Consumer Discretionary
  • LQDA Health Care
  • Exchange
  • HELE Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • HELE 1.4B
  • LQDA 1.3B
  • IPO Year
  • HELE N/A
  • LQDA 2018
  • Fundamental
  • Price
  • HELE $58.80
  • LQDA $16.12
  • Analyst Decision
  • HELE Buy
  • LQDA Strong Buy
  • Analyst Count
  • HELE 3
  • LQDA 7
  • Target Price
  • HELE $79.67
  • LQDA $26.67
  • AVG Volume (30 Days)
  • HELE 381.1K
  • LQDA 733.6K
  • Earning Date
  • HELE 01-08-2025
  • LQDA 03-12-2025
  • Dividend Yield
  • HELE N/A
  • LQDA N/A
  • EPS Growth
  • HELE N/A
  • LQDA N/A
  • EPS
  • HELE 4.95
  • LQDA N/A
  • Revenue
  • HELE $1,910,975,000.00
  • LQDA $15,610,000.00
  • Revenue This Year
  • HELE N/A
  • LQDA N/A
  • Revenue Next Year
  • HELE $6.22
  • LQDA $206.64
  • P/E Ratio
  • HELE $11.79
  • LQDA N/A
  • Revenue Growth
  • HELE N/A
  • LQDA N/A
  • 52 Week Low
  • HELE $48.05
  • LQDA $8.26
  • 52 Week High
  • HELE $127.83
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • HELE 46.22
  • LQDA 68.76
  • Support Level
  • HELE $55.00
  • LQDA $16.10
  • Resistance Level
  • HELE $57.77
  • LQDA $16.81
  • Average True Range (ATR)
  • HELE 2.01
  • LQDA 0.56
  • MACD
  • HELE 0.11
  • LQDA -0.05
  • Stochastic Oscillator
  • HELE 66.80
  • LQDA 76.20

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home & Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: